Cassava Sciences Inc. (NASDAQ: SAVA) is a biotech developing treatments for Alzheimer's disease. The company has a lot of ...

On Friday, Cassava Sciences Inc (SAVA) stock saw a decline, ending the day at $29 which represents a decrease of $-0.58 or -1.96% from the prior close of $29.58. The stock opened at $29.64 and touched ...

Cassava Sciences (NASDAQ:SAVA) traded higher in the premarket on Tuesday after the Alzheimer’s drug developer received its only buy rating on Wall Street as H.C. Wainwright upgraded the stock ...

Bearish flow noted in Cassava Sciences (SAVA) with 2,978 puts trading, or 1.3x expected. Most active are Nov-24 27 puts and Dec-24 10 puts, ...

Cassava Sciences's SAVA short percent of float has risen 7.42% since its last report. The company recently reported that it ...

PFG Investments LLC lessened its position in Cassava Sciences, Inc. (NASDAQ:SAVA – Free Report) by 10.9% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 20,380 ...

Cassava Sciences, Inc. (NASDAQ:SAVA – Get Free Report)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $25.41, but opened at $27.24.

Cassava Sciences (NASDAQ: SAVA) ended the week with a piece of dispiriting news. It's going to reach deep into its coffers to settle charges brought by the most important financial-markets ...

Investors with a lot of money to spend have taken a bearish stance on Cassava Sciences (NASDAQ:SAVA). And retail traders should know. We noticed this today when the trades showed up on publicly ...

Bearish flow noted in Cassava Sciences (SAVA) with 2,978 puts trading, or 1.3x expected. Most active are Nov-24 27 puts and Dec-24 10 puts, with total volume in those strikes near 1,500 contracts.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...